N	l marrow cells. In acute myelogenous leukemia, myeloblasts accumulate and i
1	actory or relapsed acute myelogenous leukemia (R-AML) we combined       thr
2	ts with refractory acute myelogenous leukemia.  II.  Determine the maximum 
3	ts with refractory acute myelogenous leukemia or other hematologic  maligna
4	nsplants       for acute myelogenous leukemia in second remission.  Leukemi
5	py for adults with acute myelogenous leukemia in first remission.          
6	rom  primary human acute myelogenous leukemia that appeared to harbor a   h
7	 information about acute myelogenous leukemia for patients and their famili
8	eviously untreated acute myelogenous leukemia of any FAB  subtype other tha
9	rrow (for example, acute myelogenous leukemia) when in remission or when th
10	nts With High Risk Acute Myelogenous Leukemia or CML  in Blast Crisis (Summ
11	l marrow cells. In acute myelogenous leukemia, myeloblasts accumulate and i